ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ocular Therapeutix Inc

Ocular Therapeutix Inc (OCUL)

9.78
0.56
(6.07%)
Closed October 13 4:00PM
9.30
-0.48
(-4.91%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
9.78
Bid
9.79
Ask
10.00
Volume
4,642,596
9.18 Day's Range 9.90
1.995 52 Week Range 11.31
Market Cap
Previous Close
9.22
Open
9.22
Last Trade
10
@
9.9
Last Trade Time
Financial Volume
$ 45,054,817
VWAP
9.7047
Average Volume (3m)
1,063,834
Shares Outstanding
155,921,685
Dividend Yield
-
PE Ratio
-18.89
Earnings Per Share (EPS)
-0.52
Revenue
58.44M
Net Profit
-80.74M

About Ocular Therapeutix Inc

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitation... Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Ocular Therapeutix Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker OCUL. The last closing price for Ocular Therapeutix was $9.22. Over the last year, Ocular Therapeutix shares have traded in a share price range of $ 1.995 to $ 11.31.

Ocular Therapeutix currently has 155,921,685 shares outstanding. The market capitalization of Ocular Therapeutix is $1.44 billion. Ocular Therapeutix has a price to earnings ratio (PE ratio) of -18.89.

Ocular Therapeutix (OCUL) Options Flow Summary

Overall Flow

Bearish

Net Premium

-40k

Calls / Puts

0.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

OCUL Latest News

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the...

Ocular Therapeutix™ to Present at October Ophthalmology Meetings

BEDFORD, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the...

Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024

BEDFORD, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.485.161290322589.3108.9310323979.48424033CS
40.849.395973154368.94108.4413296199.02387868CS
12225.7069408747.78106.9410638348.61903733CS
261.7621.94513715718.02104.0618583426.66118146CS
526.94244.3661971832.8411.311.99517699556.53023813CS
156-0.01-0.1021450459659.7912.51.99512060625.89744446CS
2606.94244.3661971832.8424.31.99510954597.79109537CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAMPCAMP4 Therapeutics Corporation
 10.75
(2,587.50%)
378.47k
TWGTop Wealth Group Holding Ltd
$ 7.14
(233.64%)
154.23M
NIVFNewGenIvf Group Ltd
$ 0.98
(63.42%)
58.51M
ATIFATIF Holdings Ltd
$ 1.235
(58.33%)
3.85M
VERBVerb Technology Company Inc
$ 7.91
(51.82%)
15.55M
BYUBAIYU Holdings Inc
$ 0.299
(-35.28%)
11.11M
TURBTurbo Energy SA
$ 2.1511
(-29.01%)
3.2M
SMSTDefiance Daily Target 1.5X Short MSTR ETF
$ 7.898
(-23.62%)
993.33k
VEEAVeea Inc
$ 3.27
(-23.24%)
284.95k
INHDInno Holdings Inc
$ 3.74
(-22.41%)
257.75k
JTAIJet AI Inc
$ 0.1009
(23.50%)
340.09M
CDTConduit Pharmaceuticals Inc
$ 0.116
(13.28%)
270.97M
NVDANVIDIA Corporation
$ 134.80
(-0.01%)
170.27M
LUXHLuxUrban Hotels Inc
$ 0.0532
(5.35%)
165.94M
TWGTop Wealth Group Holding Ltd
$ 7.14
(233.64%)
154.23M

OCUL Discussion

View Posts
Whalatane Whalatane 2 days ago
As per the recent conference ...recruiting is going well and the speculation is that their trial will be fully enrolled ahead of schedule .
Eyelea ...the drug they will compete with ...is still increasing sales

Kiwi
👍️0
Whalatane Whalatane 3 months ago
Anybody out there ? Nice day to have a position in OCUL
Kiwi
👍️0
Whalatane Whalatane 6 months ago
OCUL. P2 data 4/5/24
REUTERS
10:03 AM ET 04/06/2024
April 6 (Reuters) - Ocular Therapeutix Inc (OCUL):
* OCULAR THERAPEUTIX™ ANNOUNCES POSITIVE PHASE 2 PAXTRAVA™ GLAUCOMA DATA AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY 2024 ANNUAL MEETING
* OCULAR THERAPEUTIX INC (OCUL) - GENERALLY WELL TOLERATED WITH NO IMPACT ON CORNEAL HEALTH OBSERVED
* OCULAR THERAPEUTIX INC (OCUL) - CLINICALLY MEANINGFUL MEAN IOP REDUCTION OF ABOUT 24-30% FROM BASELINE OBSERVED OVER SIX MONTHS Source text for Eikon: Further company coverage:

Kiwi
👍️0
Monksdream Monksdream 6 months ago
OCUL under $10
👍️0
Monksdream Monksdream 7 months ago
OCUL 10Q due March 11
👍️0
glenn1919 glenn1919 10 months ago
OCUL....................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783
👍️0
trendzone trendzone 2 years ago
Tard sells $6.00 call option at $0.15 at the close,apparently they were born yesterday.
👍️0
glenn1919 glenn1919 2 years ago
OCUL..........................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783
👍️0
trendzone trendzone 2 years ago
Clueless fool sells $6.00 call option at $0.10 when they were just trading at $0.30,with the big rally going on in the stock today, what a total fool they are.
👍️0
cuggegrosse cuggegrosse 2 years ago
I chose OCUL to invest in because the market conditions should not effect the PPS(much),plus I can sell covered calls and make some monthly cash,besides they have products that are in demand !!!!
👍️ 1
cuggegrosse cuggegrosse 2 years ago
Yes I have noticed that
👍️ 1
Tzr250rg Tzr250rg 2 years ago
Ask is super thin wont take much to move. GLTUA
👍️0
cuggegrosse cuggegrosse 2 years ago
My eye doctor says Dextenza is a very good drug and he raccomends it !!!!!
👍️ 1
cuggegrosse cuggegrosse 2 years ago
DEXTENZA is doing very,very well,great revs expected in 2023
👍️ 1
cuggegrosse cuggegrosse 2 years ago
This company could go to $8.00 very eassy
👍️ 1
spotonge spotonge 2 years ago
boys need to wake up
👍️0
biotechslayr biotechslayr 2 years ago
Is anyone at all following OCUL into the end of the months binary? TKI data could be a game changer. Total TAM is ridiculous (look at REGN mcap!)
👍️ 1
oxnous oxnous 3 years ago
OCUL --charting


👍️0
oxnous oxnous 3 years ago
With the aging population, eye care is becoming an increasing concern. Dry eye, glaucoma, macular degeneration etc. will be expanding market sub sectors
👍️0
ClayTrader ClayTrader 3 years ago
* * $OCUL Video Chart 04-29-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
whytestocks whytestocks 4 years ago
Just In: $OCUL Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that its application for the creation of a Category I Current Procedural Ter...

In case you are interested OCUL - Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts
👍️0
whytestocks whytestocks 4 years ago
Breaking News: $OCUL Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI

OTX-CSI demonstrates improvement in signs and symptoms of Dry Eye Disease Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the ey...

Got this from OCUL - Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI
👍️0
TheFinalCD TheFinalCD 4 years ago
OCUL 10.87 NEW HIGH OF DAY
👍️0
whytestocks whytestocks 4 years ago
Just In: $OCUL Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported preliminary, unaudited net product revenue for the third quarter ended Septe...

Find out more OCUL - Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter
👍️0
now invest now invest 4 years ago
Thus far OCUL is trading nicely!!
👍️0
ClayTrader ClayTrader 4 years ago
* * $OCUL Video Chart 05-22-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 03-04-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
edwardport edwardport 5 years ago
near term 10% projected increase in market price

closed on 2/7/20 @ $5.21
👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 02-07-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 01-03-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 11-29-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
TFMG TFMG 5 years ago
OCUL - POSSIBLE 25% TREND MOVE ON THE DAILY

Ocular Therapeutix , Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

SHORT INTEREST
8.24M 07/15/19

P/E Current
-2.78

P/E Ratio (with extraordinary items)
-2.92

Average Recommendation: OVERWEIGHT

Average Target Price: 9.67

👍️0
tste9 tste9 5 years ago
Great news! BUT, hoped for more volume price etc. wow
GLA
👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 07-26-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
whytestocks whytestocks 5 years ago
News: $OCUL Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a ...

Got this from Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services
👍️0
smallbio smallbio 5 years ago

Is DEXTENZA currently only targeting medicare patients, as there is no private insurance company will reimburse the cost?
👍️0
tste9 tste9 5 years ago
What is up with this little piggy, lately! #&*#@*
👍️0
tste9 tste9 5 years ago
Great news thanks for post. Do you know of any web site that posts OCUL sales per week. Thank you. GL
👍️0
whytestocks whytestocks 5 years ago
News: $OCUL Ocular Therapeutix(TM) Announces Commercial Launch of DEXTENZA® (dexamethasone intracanalicular insert) 0.4 mg for Ophthalmic Use in the United States

Pass-through payment status and C-code from the Centers for Medicare and Medicaid Services (CMS) now active Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and ...

In case you are interested https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-commercial-launch-of-dextenza-x-8439742.html
👍️0
swingingRichard swingingRichard 5 years ago
Shorted 10,000 shares. Looking good.
👍️0
tste9 tste9 5 years ago
Shorts ease out as usual. criminal how shorts manipulate SP then just slither out unharmed. GLA
👍️0
tste9 tste9 5 years ago
YEA BABY!
👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 06-21-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
whytestocks whytestocks 5 years ago
News: $OCUL Ocular Therapeutix(TM) Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® (0.4 Dexamethasone Intracanalicular Insert for Ophthalmic Use) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

DEXTENZA ® Now Approved for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases...

Find out more https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-fda-approval-of-supplemental-new-drug-application-snda-for-dextenza-xae-0-4-dexamethasone-intracanalicular-insert-for-ophthalmic-use-for-the-treatment-of-ocular-inflammation-following-ophthalmic-surgery-8394606.html
👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 06-11-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
Tzr250rg Tzr250rg 5 years ago
low volume today
👍️0
whytestocks whytestocks 5 years ago
News: $OCUL Ocular Therapeutix(TM) Announces Receipt of C-Code and Pass-Through Payment Status for DEXTENZA®

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has approved t...

Got this from https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-receipt-of-c-code-and-pass-through-payment-status-for-dextenza-xae--8261962.html
👍️0
ClayTrader ClayTrader 5 years ago
* * $OCUL Video Chart 05-21-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
now invest now invest 5 years ago
Stopped in to see anything up.... oh well...
👍️0
RolandDoe RolandDoe 5 years ago
Hardly
👍️0

Your Recent History

Delayed Upgrade Clock